$14.59
18.14% day before yesterday
Nasdaq, Jun 06, 10:13 pm CET
ISIN
US35803L1089
Symbol
KRRO

Frequency Therapeutics Inc Stock price

$14.59
-0.21 1.39% 1M
-27.99 65.74% 6M
-23.48 61.68% YTD
-30.15 67.39% 1Y
-948.41 98.48% 5Y
-670.41 97.87% 10Y
-670.41 97.87% 20Y
Nasdaq, Closing price Fri, Jun 06 2025
+2.24 18.14%
ISIN
US35803L1089
Symbol
KRRO
Sector
Industry

Key metrics

Market capitalization $137.01m
Enterprise Value $22.06m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 4.58
P/S ratio (TTM) P/S ratio 28.42
P/B ratio (TTM) P/B ratio 0.99
Revenue (TTM) Revenue $4.82m
EBIT (operating result TTM) EBIT $-95.48m
Free Cash Flow (TTM) Free Cash Flow $-75.05m
Cash position $114.95m
EPS (TTM) EPS $-9.31
P/E forward negative
P/S forward 45.47
EV/Sales forward 7.32
Short interest 15.02%
Show more

Is Frequency Therapeutics Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,823 stocks worldwide.

Frequency Therapeutics Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Frequency Therapeutics Inc forecast:

10x Buy
100%

Analyst Opinions

10 Analysts have issued a Frequency Therapeutics Inc forecast:

Buy
100%

Financial data from Frequency Therapeutics Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
4.82 4.82
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 31 31
17% 17%
633%
- Research and Development Expense 70 70
17% 17%
1,448%
-91 -91
11% 11%
-1,896%
- Depreciation and Amortization 4.06 4.06
21% 21%
84%
EBIT (Operating Income) EBIT -95 -95
12% 12%
-1,981%
Net Profit -87 -87
8% 8%
-1,813%

In millions USD.

Don't miss a Thing! We will send you all news about Frequency Therapeutics Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Frequency Therapeutics Inc Stock News

Neutral
GlobeNewsWire
25 days ago
CAMBRIDGE, Mass., May 14, 2025 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that members of management will participate in the following upcoming investor conferences: 2025 RBC Capital Markets Global Healthcare Conference Ram Aiyar, Ph.D.
Neutral
GlobeNewsWire
about one month ago
CAMBRIDGE, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both rare and highly prevalent diseases, today reported financial results for the first quarter of 2025 and provided a business update.
Neutral
GlobeNewsWire
2 months ago
Strengthens leadership team with additional key appointment of GaoZhong Zhu, Ph.D. as Senior Vice President of Chemistry, Manufacturing and Controls (CMC) & Technical Operations and promotion of Oliver Dolan to Principal Accounting Officer Strengthens leadership team with additional key appointment of GaoZhong Zhu, Ph.D. as Senior Vice President of Chemistry, Manufacturing and Controls (CMC) & ...
More Frequency Therapeutics Inc News

Company Profile

Frequency Therapeutics, Inc. engages in the development of small molecule drugs that activate progenitor cells within the body to restore healthy tissue. Its product pipeline include Sensorineural hearing loss (FX-322), and Multiple Sclerosis. The company was founded by Robert S. Langer, Jr., David L. Lucchino, Christopher Loose and Will J. McLean on November 13, 2014 and is headquartered in Woburn, MA.

Head office United States
CEO Ram Aiyar
Employees 104
Founded 2018
Website www.korrobio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today